Over 10% of cardiology practice patients inappropriately take aspirin

the ONA take:

According to a new study published in the Journal of the American College of Cardiology, researchers from Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, have found that more than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.

For the study, researchers identified over 254,000 patients who were taking aspirin between 2008 and 2013 from the National Cardiovascular Disease Registry Practice Innovation and Clinical Experience (PINNACLE) registry. The researchers used the Framingham risk calculator to assess the 10-year risk of cardiovascular disease of the 68,808 evaluable patients.

The researchers defined inappropriate aspirin use for primary prevention as taking aspirin when a patient's 10-year risk was less than 6%; some guidelines say inappropriate use is less than a 10% risk. Results showed that 11.6% of patients taking aspirin for primary prevention had a 10-year risk of less than 6%.

In addition, when comparing inappropriate aspirin use among different cardiology practices, researchers found that inappropriate use ranged from 0% to 70% in different practices.

The findings suggest that the 10-year cardiovascular disease risk should be calculated for each patient, and the clinician should discuss the risk versus benefit of aspirin use with that patient. 

Over 10% of cardiology practice patients inappropriately take aspirin
More than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
More than 10% of patients in a representative sample of US cardiology clinics were "inappropriately" taking aspirin for primary prevention of CVD; that is, their 10-year risk for CVD was less than 6%, according to a new study.
READ FULL ARTICLE From Med Scape
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs